NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Mario Lacouture
Memorial Sloan Kettering Cancer Center - Indore / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4441083
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Mario Lacouture's MOST POPULAR ARTICLES
1-)
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working GroupI Puzanov, A Diab, K Abdallah, CO Bingham, C Brogdon, R Dadu, ...Journal for immunotherapy of cancer 5 (1), 1-28, 201712952017
2-)
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodiesJ Naidoo, DB Page, BT Li, LC Connell, K Schindler, ME Lacouture, ...Annals of Oncology 26 (12), 2375-2391, 201512922015
3-)
Mechanisms of cutaneous toxicities to EGFR inhibitorsME LacoutureNature Reviews Cancer 6 (10), 803-812, 20068362006
4-)
Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin …ME Lacouture, EP Mitchell, B Piperdi, MV Pillai, H Shearer, N Iannotti, ...Journal of Clinical Oncology 28 (8), 1351-1357, 20105392010
5-)
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicitiesME Lacouture, MJ Anadkat, RJ Bensadoun, J Bryce, A Chan, JB Epstein, ...Supportive Care in Cancer 19, 1079-1095, 20115132011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept